SCHEMBL14645035

SCHEMBL14645035

C#CCC1C(C2(C)CCC(O)CC2)CCC2(C)C(C(C)CCCC(C)C)CCC12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.55
CDC25A P30304 4/20 0.52
CDC25B P30305 1/20 0.52
NPC1L1 Q9UHC9 6/20 0.51
USP2 O75604 4/20 0.51
LMNA P02545 3/20 0.51
RORC P51449 3/20 0.50
RORA P35398 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
GPR183 P32249 1/20 0.50
ABCB1 P08183 1/20 0.50
OSBP P22059 1/20 0.50
OSBP2 Q969R2 1/20 0.50
CYP46A1 Q9Y6A2 1/20 0.50
TP53 P04637 1/20 0.50
ALOX15 P16050 1/20 0.48
CDC45 O75419 2/20 0.47
PTPRC P08575 1/20 0.47
GPBAR1 Q8TDU6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13770759 0.74 NR1H4 (0.54) NR1H4OSBPOSBP2GPBAR1
SCHEMBL24425754 0.73 NPC1L1 (0.64) NR1H4CDC25ACDC25BNPC1L1USP2
SCHEMBL19116422 0.72 NR1H4 (0.69) NR1H4USP2LMNAMEN1KMT2A
SCHEMBL20972927 0.72 GPBAR1 (0.72) CDC25ACDC25BNPC1L1USP2LMNA
SCHEMBL5341067 0.72 GPBAR1 (0.72) CDC25ACDC25BNPC1L1USP2LMNA
SCHEMBL9951526 0.72 GPBAR1 (0.72) CDC25ACDC25BNPC1L1USP2LMNA
SCHEMBL21000302 0.72 GPBAR1 (0.72) CDC25ACDC25BNPC1L1USP2LMNA
SCHEMBL20972926 0.72 GPBAR1 (0.72) CDC25ACDC25BNPC1L1USP2LMNA
SCHEMBL22472242 0.72 GPBAR1 (0.72) CDC25ACDC25BNPC1L1USP2LMNA
SCHEMBL19545492 0.72 GPBAR1 (0.72) CDC25ACDC25BNPC1L1USP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357368-B2 Methods of treating pancreatic or liver cancer using hedgehog antagonists CURIS, INC. (US) 2013-01-22 US disclosed